Sort
48,018 grants matching “immunotherapy”
Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)
$2,548,990James R. Heath · Institute For Systems Biology · U54 · FY2023 · CA
Costimulatory Mechanisms of Autoimmunity
$2,548,048David A. Hafler · Yale University · P01 · FY2023 · AI
CANCER CENTER SUPPORT GRANT
$2,547,570Gerold Bepler · Wayne State University · P30 · FY2012 · CA
Costimulatory Mechanisms of Autoimmunity
$2,546,320David A. Hafler · Yale University · P01 · FY2019 · AI
Discovering and Exploiting Mechanisms of Neuroblastoma Therapy Resistance
$2,545,516John M Maris · Children'S Hosp Of Philadelphia · P01 · FY2024 · CA
SPORE in Lymphoma
$2,545,025Johns Hopkins University · P50 · FY2005 · CA
Precision Medicine of Cancer
$2,545,004Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Experimental Therapy for Brain Tumors
$2,542,342John H Sampson · Duke University · P01 · FY2021 · CA
OVERCOMING IMMUNOTHERAPY RESISTANCE IN BREAST CANCER USING RT-MEDIATED IMMUNOMODULATION
$2,540,008Cedars-Sinai Medical Center · · FY2019 · Defense Health Agency
Spore in Head and Neck Cancer
$2,539,302David Sidransky · Johns Hopkins University · P50 · FY2014 · DE
Targeted Therapies in Melanoma
$2,538,781Meenhard Herlyn · Wistar Institute · P01 · FY2019 · CA
Costimulatory Mechanisms of Autoimmunity
$2,538,330David A. Hafler · Yale University · P01 · FY2020 · AI
Molecular and Cellular Determinants of Disease Heterogeneity in COPD
$2,538,101Frank C. Sciurba · University Of Pittsburgh At Pittsburgh · P50 · FY2009 · HL
Experimental Therapy for Brain Tumors
$2,536,844John H Sampson · Duke University · P01 · FY2020 · CA
SPORE in Lymphoma
$2,534,934Johns Hopkins University · P50 · FY2004 · CA
Transforming Human Pancreatic Cancer Into An Immunologic Disease
$2,530,690Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2023 · CA
Transforming Human Pancreatic Cancer Into An Immunologic Disease
$2,530,688Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2022 · CA
Cellular Control: Synthetic Signaling/Motility (RMI)
$2,530,000Wendell A Lim · University Of California, San Francisco · PN2 · FY2010 · EY
CANCER CENTER SUPPORT GRANT
$2,529,146Gerold Bepler · Wayne State University · P30 · FY2015 · CA
Preclinical drug development in pancreatic cancer
$2,528,211Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
LICI Microbiome and Genetics Core
$2,525,817Colm Ohuigin · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA
Tissue compartmentalization of human lymphocytes
$2,525,606Donna L Farber · Columbia University Health Sciences · P01 · FY2013 · AI
The Cellular Geography of Therapeutic Resistance in Cancer
$2,524,826Bruce E. Johnson · Dana-Farber Cancer Inst · U2C · FY2019 · CA
The Cellular Geography of Therapeutic Resistance in Cancer
$2,524,826Eliezer M Van Allen · Dana-Farber Cancer Inst · U2C · FY2022 · CA
The Cellular Geography of Therapeutic Resistance in Cancer
$2,524,824Bruce E. Johnson · Dana-Farber Cancer Inst · U2C · FY2020 · CA